Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03061890 · ClinicalTrials.gov registry record

Developmental Impact of NICU Exposures (DINE)

A clinical trial, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
600
Enrollment target

NCT03061890 is a clinical trial that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 600 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03061890 has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
600 participants
Enrollment target

Study Summary

The DINE study will test the hypothesis that potentially avoidable NICU-based exposures contribute to the neuro-cognitive and somatic impairments prevalent among NICU graduates. This hypothesis is drawn from the documented impact of phthalate exposure on early development in term-born children, and the acknowledged presence of these toxic chemicals in the NICU. Third trimester in utero exposure to phthalates have been linked to poorer childhood performance in cognition, motor function, attention, hyperactivity and social behavior. Phthalate exposure is also associated with altered onset of puberty and asthma. The multi-site cohort and approach will clarify the role of NICU-based phthalate exposure on high-prevalence clinical outcomes.

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2017-04-01
Est. Completion 2023-08-31

Sponsor

Albert Einstein College of Medicine

175 total trials

What the Registry Record Tells You About NCT03061890

The ClinicalTrials.gov registry entry for NCT03061890 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03061890 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03061890 about?

NCT03061890 is a clinical study titled "Developmental Impact of NICU Exposures (DINE)". The DINE study will test the hypothesis that potentially avoidable NICU-based exposures contribute to the neuro-cognitive and somatic impairments prevalent among NICU graduates. This hypothesis is drawn from the documented impact of phthalate exposure on early development in term-born children, and ...

What is the current status of trial NCT03061890?

This trial is currently completed. The enrollment target is 600 participants. The study started on 2017-04-01. Estimated completion is 2023-08-31.

Who is sponsoring clinical trial NCT03061890?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.